These independent CME activities are supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.



Clinical Context:
Stroke Prevention in Atrial Fibrillation
  1. Course List
Chair
faculty image
Clyde W. Yancy, MD, MSc
  • Vice Dean, Diversity & Inclusion
  • Associate Director, Bluhm Cardiovascular Institute
  • Magerstadt Professor of Medicine,
  • Chief, Division of Cardiology
  • Northwestern University, Feinberg School of Medicine
  • Chicago, Illinois
  • Clinical Context: Stroke Prevention in
    Atrial Fibrillation
    is designed to provide up-to-date information on patient identification, risk factors, and current and emerging treatments and best practices in the management of atrial fibrillation.

    The curriculum includes:
    • 6 case studies
    • MedPage Today meeting coverage that will report on cutting-edge news as it breaks from the European Society of Cardiology (ESC) Congress 2015, Transcatheter Cardiovascular Therapeutics (TCT) 2015, American Heart Association Scientific Sessions 2015 (Nov.), International Stroke Conference 2016, and the American College of Cardiology (ACC) 65th Annual Scientific Session & Expo (2016)
    • Activities based on new and emerging data from studies published in peer-reviewed journals
    • Hallway buzz segments with video

    Target Audience

    Cardiologists, neurologists, clinical cardiac electrophysiologists, primary care physicians, nurses, pharmacists, and other clinicians involved in the screening and treatment of patients with atrial fibrillation.

     

    Activity Goal

    The goal of this program is to provide information and case studies at the point of care on current and emerging management strategies based on the most up-to-date evidence-based medicine and clinical trial results in stroke prevention in atrial fibrillation.